DOSTARLIMAB
UNII P0GVQ9A4S5

Substance Identification & Data

This profile provides standardized clinical and technical data for Dostarlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P0GVQ9A4S5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2022215-59-2 and the RxNorm Concept ID (RxCUI) 2539967. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

P0GVQ9A4S5

CAS Registry Number

2022215-59-2

RxNorm Concept ID

2539967

Detailed Substance Profile

Preferred Name

DOSTARLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

P0GVQ9A4S5

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C126799

National Cancer Institute reference terminology for clinical and research data.

INN ID

10787

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-55

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dostarlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DOSTARLIMAB

DOSTARLIMAB-GXLY

Common Names & Synonyms

DOSTARLIMAB [INN]

DOSTARLIMAB [USAN]

DOSTARLIMAB [WHO-DD]

DOSTARLIMAB GXLY [WHO-DD]

Brand / Trade Names

JEMPERLI

Systematic Nomenclature

IMMUNOGLOBULIN G4, ANTI-(PROGRAMMED CELL DEATH PROTEIN 1 (PDCD1)) (HUMANIZED CLONE ABT1 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED CLONE ABT1 .KAPPA.-CHAIN, DIMER

SYS

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HUMAN PROGRAMMED CELL DEATH PROPTEIN 1 (PROTEIN PD-1, CD279 ANTIGEN))HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.4 HEAVY CHAIN (1-440) (HUMANIZED VH (HOMO SAPIENS IGHV3-23*01 (92%) (IGHD)-IGHJ6*01 (93%)) (8.8.6) (1-113) -HOMO SAPIENS IGHG4*01 (CH1 C27>G(140), H87>K(200), K88>H(201), H S10>P(221)) (114-440)) (127-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-39*01 (92%) IGKJ4*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (107'-214')), DIMER (219-219'':222-222'')-BISDISULFIDE

SYS